Merck & Co., Inc. Accounts Payable 2008-2026 | MRK
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is Merck & Co., Inc.'s current accounts payable?
Merck & Co., Inc. (MRK) annual accounts payable for 2025 was $4.40B, a 7.97% increase from 2024. Merck & Co., Inc. accounts payable for the quarter ending March 31, 2026 was $3.86B.
What was Merck & Co., Inc.'s accounts payable in 2024?
Merck & Co., Inc. annual accounts payable for 2024 was $4.08B, a 4.00% increase from 2023.
What was Merck & Co., Inc.'s accounts payable in 2023?
Merck & Co., Inc. annual accounts payable for 2023 was $3.92B, a 8.02% decline from 2022.
What is Merck & Co., Inc.'s 5-year accounts payable CAGR?
Merck & Co., Inc. accounts payable grew at a compound annual growth rate (CAGR) of 0.35% from FY2020 to FY2025, going from $4.33B to $4.40B over 5 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+0.4%
FY2020
$4.33B
→
FY2025
$4.40B
080910111213141516171819202122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.40B | +8.0% | 10-K |
| FY2024 | $4.08B | +4.0% | 10-K |
| FY2023 | $3.92B | -8.0% | 10-K |
| FY2022 | $4.26B | -7.5% | 10-K |
| FY2021 | $4.61B | +6.5% | 10-K |
| FY2020 | $4.33B | +15.8% | 10-K |
| FY2019 | $3.74B | +12.7% | 10-K |
| FY2018 | $3.32B | +7.0% | 10-K |
| FY2017 | $3.10B | +10.5% | 10-K |
| FY2016 | $2.81B | +10.8% | 10-K |
| FY2015 | $2.53B | -3.5% | 10-K |
| FY2014 | $2.63B | +15.4% | 10-K |
| FY2013 | $2.27B | +29.7% | 10-K |
| FY2012 | $1.75B | -13.3% | 10-K |
| FY2011 | $2.02B | -12.3% | 10-K |
| FY2010 | $2.31B | +2.9% | 10-K |
| FY2009 | $2.24B | +263.3% | 10-K |
| FY2008 | $617.6M | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →